Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
Go back to Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026| (NASDAQ: STRO) | Delayed: 30.45 -1.1 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.55 | 52 Week High | $ | |||
| Open | $30.67 | 52 Week Low | $ | |||
| Day High | $32.76 | P/E | N/A | |||
| Day Low | $30.00 | EPS | $ | |||
| Volume | 109,734 | |||||

